Google
×
AllBooksImagesNews Maps Videos Shopping
Search tools
Archives
  • Recent
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
  • Archives
Sorted by relevance
Clear

Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach

Molecular Neurodegeneration
Diagnosis of dementia with Lewy bodies (DLB) is challenging, largely due to a lack of diagnostic tools. Cerebrospinal fluid (CSF) biomarkers...
54 months ago

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Nature
In this review, we consider the capabilities and limitations of fluid biomarkers collected from cerebrospinal fluid, blood, and oral, ocular, and olfactory...
68 months ago

Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

Wiley Online Library
Cerebrospinal fluid (CSF) has been extensively studied to explore biochemical alterations in subjects with neurodegenerative disorders.
111 months ago

Biofluid biomarkers for Alzheimer’s disease

Frontiers
Alzheimer's disease (AD) is a multifactorial neurodegenerative disease, with a complex pathogenesis and an irreversible course.
6 months ago

Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia

Nature
We conclude that CSF LCN2 is a promising candidate biochemical marker in the differential diagnosis of VaD and neurodegenerative dementias.
59 months ago

Dementia with Lewy bodies: an update and outlook

Molecular Neurodegeneration
Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder producing progressive cognitive decline that interferes with normal life and...
71 months ago

Added value of cerebrospinal fluid multimarker analysis in diagnosis and progression of dementia

Wiley Online Library
The added value of emerging cerebrospinal fluid (CSF) markers (Aβ40, Aβ38, BACE-1, neurogranin [ng], phosphorylated neurofilament heavy...
49 months ago

Cerebrospinal Fluid Biomarker Candidates for Parkinsonian Disorders

Frontiers
Reliable biomarkers are needed for early and accurate diagnosis, to measure disease progression, and response to therapy.
11 months ago

CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease

Nature
Diagnosis of dementia with Lewy bodies (DLB) is challenging and specific biofluid biomarkers are highly needed.
15 months ago

Potential New Approaches for Diagnosis of Alzheimer's Disease and Related Dementias

Frontiers
Dementia is an umbrella term—caused by a large number of specific diagnoses, including several neurodegenerative disorders. Alzheimer's disease (AD) is now...
11 months ago